Proceedings from the 2 nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019

For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed with life-threatening chronic complications, in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pediatric rheumatology online journal 2020-07, Vol.18 (Suppl 1), p.53
Hauptverfasser:	Canna, Scott W, Schulert, Grant S, de Jesus, Adriana, Pickering, Alex, Brunner, Hermine, Gadina, Massimo, Levine, Stewart, Goldbach-Mansky, Raphaela, Boutelle, Jonathan, Sinha, Rashmi, DeBenedetti, Fabrizio, Grom, Alexei
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis, Juvenile - diagnosis Arthritis, Juvenile - pathology Arthritis, Juvenile - therapy Biomarkers Child Child, Preschool Disease Progression Humans Infant Macrophage Activation Syndrome - diagnosis Macrophage Activation Syndrome - pathology Macrophage Activation Syndrome - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!